CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
87,387,588
Share change
+6,120,690
Total reported value
$2,433,954,441
Put/Call ratio
104%
Price per share
$27.87
Number of holders
193
Value change
+$175,704,195
Number of buys
106
Number of sells
71

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q1 2015

As of 31 Mar 2015, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 193 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,387,588 shares. The largest 10 holders included FMR LLC, OPPENHEIMER FUNDS INC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., COLUMBIA WANGER ASSET MANAGEMENT LLC, LORD, ABBETT & CO. LLC, and STATE STREET CORP. This page lists 193 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.